This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Diffuse large B-cell lymphoma
HLP_C3_DLBCL
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Cancer registry: Topography ICD-O-3
ANY
Cancer registry: Morphology ICD-O-3
9680
Cancer registry: Behaviour codes
3
1 out of 7 registries used, show all original rules.
1036
Check minimum number of events None
1036
Include endpoints None
1036
Remove individuals based on genotype QC
1010
HLP_C3_DLBCL
Control definitions
Control exclude
C3_CANCER, C3_CANCER_WIDE
Extra metadata
First used in FinnGen datafreeze
DF8
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Diffuse large B-cell lymphoma
based on the number of shared cases.
Broader endpoints:
- Diffuse large B-cell lymphoma
- Diffuse large B-cell lymphoma (controls excluding all cancers)
- Malignant neoplasm (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1010 | 434 | 576 |
| Unadjusted prevalence (%) | 0.27 | 0.21 | 0.35 |
| Mean age at first event (years) | 65.68 | 63.81 | 67.09 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: HLP_C3_DLBCL – Diffuse large B-cell lymphoma
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Diffuse large B-cell lymphoma
↥Endpoint not on priority list, no data to show.